Horizon Analytical has a working certificate-of-analysis (COA) verification system and openly reports its methods, prices, and accreditation status. However, the public evidence base is thin, and the laboratory has a minimal organizational footprint. These findings provide useful signals about report handling, but not a complete basis for judging analytical competence.
Horizon Analytical's stated methods and operating model
Horizon Analytical names HPLC/MS instrumentation, meaning liquid chromatography combined with mass spectrometry, and publishes per-sample prices of 160.00-350.00 USD. Its listed services include Peptide Vial, Peptide Blends, GLP-1 Vial, and GLP-1 Capsule HPLC/MS. The laboratory states plainly that it holds no accreditation and claims none. That is an honest disclosure, and no false accreditation is claimed. Its ordering route is for business customers only; no private ordering route was found.
How does Horizon Analytical's certificate verification work?
The strongest positive signal is a functional portal at horizonanalytical.com/verify-coa. Starting from a real certificate, the printed verification route was followed back to the issuer and worked. This supports report governance, meaning that reports can be checked against an issuer, but it does not by itself prove analytical competence. Horizon Analytical displays verified certificates for Kisspeptin-10, Retatrutide, Semax, Tirzepatide, Cagrilintide, Tesamorelin, MOTS-c, PT-141, and Thymosin Alpha-1.
Independent evidence remains limited
No independent third-party corroboration was found. The supplied sources contain no business-register entry, named real person, forum discussions, or peer-reviewed references. The only external mentions are two unverified customer reviews on Reviews.io. The domain is approximately 263 days old, and the website claims no years of operation. Generic stock photography and placeholder text are also present as template-site artifacts.
How should you read this result?
These observations are signals, not a verdict. No concrete open concern rises to a Watch level, but the limited independent evidence means the positive verification findings should be read with appropriate restraint.
